Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 34 Neoplasms 10 Prostatic Neoplasms 6 Neoplasm Metastasis 6 Carcinoma, Ovarian Epithelial 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Ovarian Neoplasms 4 Lymphoma, Mantle-Cell 4 Lymphoma, Follicular 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms, Male 4 Stomach Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Large-Cell, Anaplastic 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, B-Cell, Marginal Zone 3 Lymphoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Carcinoma, Renal Cell 3 Burkitt Lymphoma 3 Wilms Tumor 2 Testicular Neoplasms 2 Teratoma 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Salivary Gland Neoplasms 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Pancreatic Neoplasms 2 Osteosarcoma 2

Interventions

Ipilimumab 114 pembrolizumab 95 Nivolumab 91 aldesleukin 86 Interleukin-2 57 Cyclophosphamide 54 Dacarbazine 52 Vemurafenib 39 trametinib 37 Temozolomide 37 incomplete Freund's adjuvant 35 fludarabine phosphate 35 sargramostim 32 dabrafenib 32 fludarabine 26 Bevacizumab 26 Paclitaxel 22 MART-1 Antigen 21 Granulocyte-Macrophage Colony-Stimulating Factor 21 montanide ISA 51 20 Interferon-alpha 20 Cisplatin 20 Carboplatin 19 Sorafenib 18 Introns 17 Biopsy 17 cobimetinib 16 Radiosurgery 16 atezolizumab 15 Radiotherapy 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Melanoma × ixabepilone × Clear all

NCT00036764 2013-01-25

BMS-247550 in Treating Patients With Stage IV Melanoma

National Cancer Institute (NCI)

Phase 2 Completed

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡